On August 31, 2022, Dr. Adrian Kilcoyne informed Humanigen, Inc. of his resignation from his position as Chief Medical Officer of the Company, effective September 28, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% | 0.00% | -83.33% |
01/05 | Combined Hearing for Disclosure Statement and Plan Approved for Humanigen, Inc. | CI |
12/04 | Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-83.33% | 23.82T | |
-0.67% | 9.23TCr | |
-2.63% | 3.81TCr | |
-12.76% | 3.29TCr | |
+66.54% | 2.65TCr | |
-13.02% | 1.57TCr | |
-5.27% | 1.34TCr | |
-10.50% | 1.17TCr | |
-49.11% | 1.01TCr | |
+187.82% | 977.87Cr |
- Stock Market
- Equities
- HGENQ Stock
- News Humanigen, Inc.
- Humanigen, Inc. Announces Resignation Adrian Kilcoyne as Chief Medical Officer, Effective September 28, 2022